Best GLP-1 Online Programs in 2026: 5 Compared, Priced, and Ranked

The best GLP-1 online programs in 2026 split cleanly into two camps: Ro (sponsored affiliate link, opens in a new tab) if you're using insurance or want FDA-approved medication, and Embody (sponsored affiliate link, opens in a new tab) if you're paying cash and want the easiest way to start. We reviewed publicly available pricing, medication paths, and policies across more than 20 programs to get there. Most comparison pages we found are already outdated — the GLP-1 landscape shifted hard this year, and the programs that deserved the top spot a year ago aren't the best picks today.

Here's the bottom line, up front:

• Using insurance? Ro is the strongest pick. It prescribes FDA-approved medications like Wegovy and Zepbound, and its insurance concierge handles the prior-authorization paperwork for you. Membership is $39 the first month, then $149/month, with medication billed separately.
• Paying cash and want to start fast? Embody is our top cash-pay pick. Compounded semaglutide injections start at $99 for the first month, there's no separate membership fee, a licensed clinician reviews your intake before anything is prescribed, and longer flat-price plans bring the ongoing cost down to as little as about $149/month.

One honest heads-up most comparison sites bury: compounded GLP-1 medications are under heavier FDA scrutiny in 2026. That doesn't make them off-limits — but it does mean which provider you pick matters more than ever. We'll explain exactly what changed below so you can choose with confidence instead of guessing.

Sponsored affiliate links — open in a new tab

Best GLP-1 Online Programs: Quick Verdict

The best GLP-1 online program depends on one thing: insurance or cash. For insurance users and anyone who specifically wants FDA-approved medication, Ro is the best overall — FDA-approved meds, an insurance concierge, included labs, and coaching, from $39 the first month. For cash-pay shoppers who want the lowest-friction way to start, Embody is the top pick: compounded semaglutide injections from $99 the first month, no membership fee, and a real clinician review before treatment.

Everyone else on this list serves a narrower need: TrimRx (sponsored affiliate link, opens in a new tab) for a simple low ongoing price, Willow (sponsored affiliate link, opens in a new tab) for a compounded dissolvable tablet. We moved MEDVi out of our top picks after the FDA named it in a February 2026 round of warning letters — more on that below.

How Do the Top GLP-1 Online Programs Compare?

We narrowed 20+ programs down to these based on medication path, pricing, medical oversight, and policy transparency. The short version: Ro wins for FDA-approved medication and insurance; Embody wins for the cheapest, fastest cash-pay start.

Which GLP-1 Program Is Right for You?

You don't need to read this whole page to find your answer. Use this quick filter.

#1. Ro — Best Overall GLP-1 Program (FDA-Approved + Insurance)

Ro is the best overall GLP-1 online program for people who want FDA-approved medication or plan to use insurance. It's the clearest FDA-approved-first telehealth path we found — not a compounded alternative — with insurance navigation, lab testing, health coaching, and provider messaging all in one app. Membership is $39 for the first month, then $149/month, with medication billed separately.

What Makes Ro Different

Ro prescribes FDA-approved GLP-1 medications: Wegovy (semaglutide — weekly injection or the newer daily pill), Foundayo (orforglipron — daily oral pill), Zepbound (tirzepatide — KwikPen or vial), and Ozempic (semaglutide, FDA-approved for type 2 diabetes). These have gone through full FDA review. That matters.

Insurance concierge. This is the feature that separates Ro from nearly every competitor. If you have private insurance, Ro's team checks your coverage, submits prior authorizations, fights denials, and handles the paperwork — included in your membership. This level of insurance support is uncommon among self-pay-first telehealth programs.

Manufacturer-backed cash-pay pricing. Ro has direct partnerships with LillyDirect (Zepbound KwikPen/vials, Foundayo) and NovoCare (Wegovy) to offer manufacturer-direct pricing — the same price as ordering directly from the drug maker, but with a doctor, coaching, and support built in.

Labs included. When your Ro provider orders metabolic lab testing, it's included through Quest Diagnostics at no extra cost. Most competitors skip labs or charge separately.

The Wegovy pill. Ro offers the FDA-approved oral Wegovy — a daily pill, not a weekly injection. For people who hate needles but want FDA-approved medication, this is significant.

Health coaching. Membership includes 1:1 coaching, a structured curriculum (nutrition, exercise, sleep, habits), and unlimited provider messaging.

What Ro Actually Costs

Ro's pricing has two separate parts — let's be direct:

• Membership: $39 first month, then $149/month (or as low as $74/month with annual prepay). Covers consultations, labs, coaching, insurance concierge, and app access. Does not include medication.
• Medication (billed separately): Wegovy pill and Foundayo from $149/month; Zepbound KwikPen from $299/month; Wegovy pen from $199/month for starting doses (intro pricing through December 31, 2026), then up to $399/month. With insurance: your copay only.
• Your real monthly total: As low as ~$298/month on cash-pay (membership + Wegovy pill starting dose), and potentially much less with insurance.

How the Insurance Concierge Saves Money

When your Ro provider prescribes a GLP-1, Ro's team contacts your insurer directly, confirms coverage, submits the prior authorization, and appeals denials (which happen often with GLP-1s). Brand-name medications like Wegovy and Zepbound carry list prices over $1,000/month. If insurance covers them, your out-of-pocket drops to a copay — often $25–$75/month. The $149 membership becomes a rounding error.

The catch: Only about 19% of large employer health plans covered GLP-1s for weight loss as of 2025. If Ro can't get you covered, they'll point you to the best cash-pay option at manufacturer-direct pricing — so you've lost nothing but the hours of phone calls you'd have made yourself.

Who Ro Is NOT For

• If you want the lowest monthly cost and don't need FDA-approved medication, Ro's membership-plus-medication total runs higher than cash-pay compounded programs.
• If you have Medicare or Medicaid, Ro's concierge can't navigate government plans for weight-loss coverage (cash-pay options remain).
• If you just want a prescription and nothing else, you're paying for coaching you may not use.

#2. Embody — Best Cash-Pay GLP-1 Injection Program to Start Fast

If you're paying cash and want the easiest GLP-1 injection program to start without insurance delays, Embody is our top pick. Compounded semaglutide injections start at $99 for the first month, compounded tirzepatide injections start at $149 for the first month, there's no separate membership fee, and a licensed clinician reviews your intake before treatment is prescribed.

What Sets Embody Apart

The lowest first-month price on this list. Embody's Start Program begins at $99 for your first month of compounded semaglutide injection — the lowest entry point of any program we reviewed. That makes it a low-friction way to try treatment without a big upfront commitment.

No membership fee, no hidden fees. Unlike Ro's $149/month membership, Embody charges no separate membership and advertises no hidden fees. You pay for medication, supplies, clinician review, and shipping in one price.

Fast, no-insurance-hassle start. Embody doesn't bill insurance, so there's no coverage check and no prior authorization to wait on. Intake takes about five minutes, and a licensed provider reviews your chart — often within a day.

Clinician-reviewed, not a checkout cart. A licensed clinician reviews your health profile and issues a prescription only if treatment is appropriate, and medication is fulfilled by state-licensed compounding pharmacy partners.

Available in all 50 states, LegitScript-certified. Embody operates nationwide and is listed as LegitScript-certified — a third-party verification of telehealth and pharmacy compliance standards.

HSA/FSA eligible. Embody advertises HSA/FSA eligibility, which can soften the monthly cost — confirm with your plan administrator before paying.

Embody Pricing (Two Tracks — Read This Before You Check Out)

Embody pricing is easiest to understand as two separate tracks, and the difference matters for your budget:

• Start Program (lowest first month): Compounded semaglutide injection is $99 for month one, then $299/month. Compounded tirzepatide injection is $149 for month one, then $399/month.
• Flat Program (lowest long-term price): Compounded semaglutide injection is $199/month month-to-month, dropping on longer commitments to as little as about $149/month on the 12-month plan. Tirzepatide adds roughly $100/month.

Here's the honest, useful part: the default checkout can funnel you into the higher-priced Start Program, where $99 jumps to $299 after month one. If a low ongoing price matters to you, choose the Flat Program from the start — that's where Embody is genuinely competitive long-term. And if you'd rather a simple low month-to-month rate with no longer commitment at all, TrimRx (~$199/month) is worth comparing.

The Honest Tradeoff

Embody is compounded, like every option in this section. Compounded medications are not FDA-approved as finished products and have not been reviewed by the FDA for safety, effectiveness, or manufacturing quality. That's a real tradeoff, and it's category-wide, not unique to Embody. If you want the strongest regulatory assurance, the FDA-approved path through Ro is the better choice. But if cost rules that out and you're comfortable with the compounded tradeoff, Embody's combination of a low entry price, a real medical review, state-licensed pharmacy partners, and fast access is the strongest cash-pay package we found for getting started.

Who Embody Is Best For

• Cash-pay shoppers with no insurance coverage for weight-loss medication
• People who want the lowest first-month price to try a GLP-1
• Anyone who wants to start now without a membership or insurance delays
• People comfortable with a once-weekly injection

Who Should Skip Embody

• If you have insurance or want FDA-approved medication → Ro
• If injections are a hard no → Ro (oral Wegovy/Foundayo) or Willow (dissolvable tablet)
• If you want the lowest simple month-to-month price → TrimRx

#3. TrimRx — Lowest Simple Ongoing Price

If you want straightforward compounded GLP-1 access at a low monthly cost with no long commitment, TrimRx (sponsored affiliate link, opens in a new tab) is the pick. Compounded semaglutide starts at approximately $199/month month-to-month, with compounded tirzepatide around $349/month. No frills, no membership, free delivery.

What TrimRx Gets Right

A low ongoing price without a longer plan. TrimRx positions itself around flat, all-inclusive pricing with free delivery. If you want a low monthly rate but don't want to lock into Embody's longer Flat plan to get there, TrimRx is the simpler route.

Personalized dosing. Treatment plans are tailored to your response, with dose adjustments based on progress.

Ongoing check-ins. You can connect with the care team for side-effect management and dose changes.

The Honest Note

TrimRx has drawn some billing and cancellation complaints in user reviews. Read the cancellation terms in full before you pay, and keep records of your subscription settings. It's a lean, medication-focused program — if you want hands-on coaching, Ro is a better fit.

#4. Willow — Best Dissolvable-Tablet Alternative for Needle-Averse Patients

Willow (sponsored affiliate link, opens in a new tab) is a solid pick for needle-averse patients who want a compounded dissolvable tablet and flat, predictable pricing. It offers a mint-flavored dissolvable semaglutide tablet alongside injectable options, at a flat $299/month with no dose-based price increases.

What Willow Offers

• Dissolvable semaglutide tablet — compounded, mint-flavored, dissolves under the tongue. No needles, no vials.
• Injectable options — compounded semaglutide and tirzepatide for people comfortable with needles.
• Fast approval — many patients approved within hours.
• Flat pricing — $299/month, no surprises at higher doses.
• Free 2-day shipping.

The Important Nuance

Willow's dissolvable tablets are compounded semaglutide — not the FDA-approved Wegovy pill. The Wegovy pill (available through Ro) went through full FDA review and clinical trials; Willow's tablets are prepared by licensed compounding pharmacies. Both are legitimate paths, but they're different regulatory categories. If FDA-approved oral medication matters to you, go with Ro. If you're comfortable with a compounded dissolvable tablet, Willow is a fair choice.

Who Should Look Elsewhere

• Budget-conscious patients → Embody (cheaper to start) or TrimRx (low simple ongoing)
• Anyone wanting FDA-approved oral medication → Ro's Wegovy pill or Foundayo
• People wanting the lowest first-month cost → Embody (from $99)

MEDVi — Why We Moved It Out of Our Top Picks

We previously ranked MEDVi among our top compounded programs. We moved it out of our top recommendations because, on February 20, 2026, the FDA named MEDVi in a round of warning letters to telehealth companies over compounded GLP-1 marketing. Here's the full, fair context so you can decide for yourself.

What actually happened: the FDA sent warning letters to 30 telehealth companies that day over website claims about compounded GLP-1 drugs. This was an industry-wide enforcement action — not an investigation aimed at MEDVi alone — and it followed more than 100 similar letters the agency sent across 2025. MEDVi's letter specifically cited compounded semaglutide and tirzepatide marketing, product labeling that suggested MEDVi was the compounder, and claims such as “same active ingredient as Wegovy/Ozempic” and “same active ingredient as Mounjaro/Zepbound,” which the FDA said implied an approval or evaluation that had not occurred.

Two things are equally true and worth holding together:

1. A warning letter is not a finding of guilt. The FDA's own manual describes warning letters as informal, advisory communications, and companies are given an opportunity to correct the issues. MEDVi has stated publicly that it responded to the FDA.
2. It's still a documented regulatory action, and our editorial standard is that we don't feature providers with active, unresolved warning letters as “winners” — the same standard we apply to MyStart Health and SkinnyRx.

MEDVi remains an operating program with a deep menu and a real customer base. We're not calling it unsafe or illegal. But while this is open, we won't present it as a top pick.

If you were drawn to MEDVi for the low cash-pay price and the choice of injection or tablet, Embody offers a similar compounded path with a lower first-month price ($99 vs. MEDVi's $179) and no membership fee.

Worth Watching: Hims & Hers

We considered ranking Hims & Hers, and they may earn a spot soon. In early 2026, following a Novo Nordisk partnership, Hims & Hers shifted toward FDA-approved GLP-1 medications — offering Wegovy pills, Wegovy injections (via NovoCare), and Ozempic at competitive cash-pay prices. Notably, Hims pulled its compounded semaglutide pill from the market shortly after launch amid the FDA's tightening stance, and Novo Nordisk has separately sued Hims & Hers over its prior compounded-semaglutide marketing.

Why they're not in our top picks yet: Hims/Hers still lacks an insurance concierge and doesn't offer tirzepatide. For patients who want insurance help or the broadest medication selection, Ro remains stronger. If you want a polished, consumer-friendly app with FDA-approved brand-name medication and you don't need insurance navigation, Hims (male-coded) and Hers (female-coded) are worth a look.

What Changed in 2026 (Including the FDA Crackdown)

If every GLP-1 site seems to say something slightly different, here's why: the ground shifted in 2026, and most pages haven't caught up. Three changes matter most.

1. FDA-Approved Pills Arrived, and Brand-Name Cash Prices Dropped

The FDA approved oral Wegovy (semaglutide tablets) for weight loss, and it became available through providers like Ro in early 2026. Foundayo (orforglipron) followed as the first FDA-approved oral small-molecule GLP-1. Around the same time, brand-name cash-pay prices fell sharply through manufacturer programs: Wegovy pill and Foundayo from $149/month, Zepbound KwikPen/vials from $299/month via LillyDirect, Wegovy pen from $199/month for starting doses. A year ago, these brand-name medications cost $1,000+/month without insurance. The gap between “affordable compounded” and “expensive brand-name” has narrowed sharply. Confirm current brand-name pricing and approval details directly — these change frequently.

2. The FDA Is Actively Cracking Down on Compounded GLP-1 Marketing

This is the change most affiliate pages won't tell you about, and you deserve to know it. After the semaglutide and tirzepatide shortages were resolved (tirzepatide in December 2024, semaglutide in early 2025), the special allowance that let compounding pharmacies mass-produce copies of Wegovy, Ozempic, and Zepbound ended. Then, on February 20, 2026, the FDA issued warning letters to 30 telehealth companies over compounded GLP-1 marketing claims.

What this means for you, in plain terms:

• Compounded GLP-1s remain available when a licensed clinician prescribes them for an individual patient whose needs can't be met by an FDA-approved product, and a licensed pharmacy fills them. They have not been banned.
• But access is narrower and more scrutinized than during the shortage. Now that semaglutide and tirzepatide are off the FDA's shortage list, pharmacies can't routinely compound what are essentially copies of the commercially available brand-name drugs.
• Choose a provider that compounds through licensed pharmacies and requires a genuine medical review — like Embody, TrimRx, and Willow on this list.

3. The FDA and ADA Have Raised Quality Concerns About Compounded Products

The FDA states that compounded drugs are not reviewed for safety, effectiveness, or quality before they're marketed, and that they should be used only when a patient's needs can't be met by an FDA-approved drug. The American Diabetes Association recommends against using non-FDA-approved compounded GLP-1 and dual GIP/GLP-1 products because of uncertainty about their content, safety, quality, and effectiveness, and notes these products have been associated with dosing errors and adverse events.

The practical takeaway: If you can access FDA-approved medication through insurance or affordable cash-pay pricing (both possible through Ro), that's the most regulatory-stable path. If cost rules that out, compounded remains a legitimate, clinician-supervised option — just choose a reputable program and go in with clear eyes.

FDA-Approved vs. Compounded GLP-1: Which Path Is Right for You?

This is the single most important distinction in the GLP-1 space right now. FDA-approved medications (Wegovy, Zepbound, Ozempic) went through full FDA review — clinical trials, manufacturing quality checks, and ongoing safety monitoring. Compounded semaglutide and tirzepatide are prepared by licensed pharmacies based on an individual prescription and have not undergone FDA review as finished products. They are not the same thing, and you shouldn't treat them as interchangeable.

Choose the FDA-approved path if:

• You have insurance that might cover it (Ro's concierge checks for free)
• You want the strongest regulatory assurance of safety and quality
• You can access cash-pay pricing through manufacturer programs
• The Wegovy pill or Foundayo appeals to you as a needle-free option

Choose the compounded path if:

• Cost is your primary barrier and you can't access affordable FDA-approved options
• Your clinician has determined a compounded formulation fits your needs
• You've chosen a reputable program (like Embody, TrimRx, or Willow) that uses licensed pharmacies and requires a real medical review

How Much Will GLP-1 Treatment Really Cost After Month One?

The intro price gets you in the door. Here's what you'll actually pay going forward.

About the Embody Flat option: the Start Program above is the lowest first-month path, but its ongoing rate is $299/month. Embody's Flat Program lowers the ongoing rate to $199/month month-to-month, or as little as about $149/month on the 12-month plan — confirm the exact rate at checkout and pick the Flat plan deliberately if a low long-term cost is your goal.

Notice the pattern: Embody is the cheapest way to start, the Embody Flat plan or TrimRx is the cheapest to maintain, and Ro is the only path where insurance can cut your medication cost to a copay.

Can You Get a GLP-1 Prescription Online Safely?

Yes — but only through a legitimate program. Every provider on this list connects you with a licensed U.S. clinician who reviews your health history, decides whether GLP-1 treatment is appropriate, and writes a prescription only if you qualify. Your medication is then dispensed by a licensed U.S. pharmacy and shipped to you.

Red Flags That Should Make You Leave a Website Immediately

• “No prescription required”
• “Instant approval” with no medical review
• No pharmacy information disclosed
• Pricing that seems impossibly low (below $100/month for injectable GLP-1s)
• No way to reach a real person
• Products labeled “for research purposes only”
• Vague “natural GLP-1 alternative” language (real GLP-1 medication is prescription-only)

How to Verify a Provider Before You Pay

1. Check for a real medical review. If you can add medication to a cart with no health screening, it's not a medical program.
2. Look for pharmacy information. Reputable providers disclose whether medications come from licensed compounding pharmacies.
3. Search the company. Check Trustpilot, the BBB, and Reddit, and search “[provider name] FDA warning letter” — exactly what we do for every program here.
4. Verify clinician licensing. The provider should be clear about whether you're seeing a physician, NP, or PA, and that they're licensed in your state.
5. Confirm follow-up care. A prescription with no follow-up is a transaction, not care.

Online GLP-1 Programs vs. Going Through Your Own Doctor

A telehealth program makes more sense when: your doctor won't prescribe GLP-1s for weight loss, you can't get an appointment for weeks, your insurance doesn't cover weight-loss visits, or you simply value the convenience of handling everything through an app. Telehealth programs typically approve patients within 24–48 hours with transparent flat pricing.

See your own doctor instead when: you have complex conditions (heart disease, kidney disease, a history of pancreatitis or thyroid cancer, or multiple interacting medications), your plan covers in-person obesity-medicine visits with low copays, or you want a physical exam and same-day labs.

Who Qualifies for Online GLP-1 Treatment?

Most online GLP-1 programs follow standard medical eligibility:

• BMI of 30 or higher (obesity), OR
• BMI of 27 or higher with at least one weight-related condition (high blood pressure, type 2 diabetes, high cholesterol, sleep apnea, etc.)

Your prescribing provider will evaluate your full medical history, current medications, and goals during intake, and may order labs (Ro includes this).

A program may say no if you have: a history of medullary thyroid carcinoma or MEN 2 syndrome, active pancreatitis, pregnancy or plans to become pregnant, certain medication interactions, or medical complexity that needs in-person evaluation.

What Results, Side Effects, and Timelines Should You Realistically Expect?

GLP-1 medications are genuinely effective — but they're not magic.

How Fast Results Start

Most people notice reduced appetite within the first few weeks. Weight loss usually becomes visible within the first month or two. The biggest results come over 6–12 months as the dose increases on a gradual titration schedule. Most people reach their maintenance dose by month 4–6.

Common Side Effects (and How to Manage Them)

Nausea, constipation, diarrhea, and reduced appetite are the most common, especially during dose increases, and for most people they improve within a few weeks. FDA-reviewed clinical trial data for FDA-approved medications reports nausea in roughly 44% of semaglutide participants, diarrhea around 30%, vomiting around 25%, and constipation around 24% (per FDA-approved Wegovy prescribing information). Serious side effects are rare but real — your provider should discuss pancreatitis, gallbladder issues, and the boxed warning about thyroid C-cell tumors (GLP-1s should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2).

Semaglutide vs. Tirzepatide

In clinical trials of the FDA-approved versions, semaglutide (Wegovy) showed average weight loss of about 15% of body weight over 68 weeks (STEP 1 trial), and tirzepatide (Zepbound) showed up to about 22.5% at the highest dose over 72 weeks (SURMOUNT-1 trial). Both are effective; your provider helps determine which fits your health profile and goals.

Important: Those results come from clinical trials of FDA-approved branded medications. Compounded semaglutide and tirzepatide have not been reviewed by the FDA as finished products and should not be described as clinically proven equivalents.

What Happens If You Stop

Clinical data shows most people regain some weight after stopping GLP-1 medication. Published follow-up from the STEP 1 extension found participants who stopped semaglutide regained roughly two-thirds of the weight they'd lost within a year. This isn't a willpower failure — it's biology. Many providers now treat GLP-1s as long-term therapy. Discuss your long-term plan with your provider.

How We Ranked These GLP-1 Programs

The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers, and we don't rank by who pays us most. Our top pick for cash-pay (Embody) and our top pick overall (Ro) are there because of medication path, price transparency, real total cost, medical oversight, and trust signals — not affiliate terms. If we stripped every affiliate link from this page, the rankings would be identical.

Why we excluded some providers you may see elsewhere: MyStart Health and SkinnyRx both received FDA warning letters related to marketing and compliance. We don't feature providers with active regulatory concerns as top recommendations — and that same standard is why we moved MEDVi out of our top picks after its February 2026 letter. We'll revisit any of them if and when their issues are resolved.

Last verified June 15, 2026. For this update we independently confirmed: Embody's two-track pricing (Start vs. Flat), its no-membership structure, its all-50-states availability and LegitScript listing; TrimRx's lower simple ongoing pricing; MEDVi's inclusion in the FDA's February 20, 2026 warning letters; and the current positions of the FDA and the American Diabetes Association on compounded GLP-1 products. Brand-name medication prices and promotional offers change frequently and should be confirmed directly with each provider before you start.

Frequently Asked Questions About the Best GLP-1 Online Programs

Your Next Step

You now understand the options better than most people six months into treatment. The hardest part isn't the medication, the side effects, or even the cost — it's the gap between “I know I should do this” and actually starting.

• If you have insurance (or think you might): Ro is the move. Its concierge checks your coverage for free; if you're covered, you pay your copay; if not, they set you up with a solid cash-pay option — all with FDA-approved medication and a real care team.
• If you're paying cash and want the easiest way to start: Embody is $99 your first month, with no membership fee, a real clinician review, and fast free shipping if you're approved. Pick the Flat Program at checkout if you want the lowest long-term price.
• If your priority is a low ongoing price with no long commitment: TrimRx runs about $199/month.

This guide is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription medications that require evaluation by a licensed healthcare provider. Compounded medications have not been reviewed by the FDA for safety, effectiveness, or quality as finished products. Prices shown were reviewed as of June 15, 2026 and are subject to change — confirm current pricing directly with each provider before starting treatment. Some links on this page are affiliate links; if you start a program through them, we may earn a commission. This never changes our rankings or recommendations.